Funding Rounds
Casinvent Pharma

Casinvent Pharma Seed (2024, $1M)

Casinvent Pharma

CK1 inhibitors developer for solid and hematologic cancers.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $1.73M

Investors